A Study of NTX-1472 in Social Anxiety Disorder
Public ClinicalTrials.gov record NCT07323784. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of NTX-1472, a V1a Receptor Antagonist, in Adults With Social Anxiety Disorder
Study identification
- NCT ID
- NCT07323784
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Newleos Therapeutics, Inc.
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- NTX-1472 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 8, 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
- Last update posted
- Jul 8, 2026
2025 – 2027
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SOAR Clinical Study Site | Encino | California | 91316 | Recruiting |
| SOAR Clinical Study Site | Los Angeles | California | 90025 | Recruiting |
| SOAR Clinical Study Site | Oceanside | California | 92056 | Recruiting |
| SOAR Clinical Study Site | San Jose | California | 95124 | Recruiting |
| SOAR Clinical Study Site | Jacksonville | Florida | 32256 | Recruiting |
| SOAR Clinical Study Site | Tampa | Florida | 33615 | Recruiting |
| SOAR Clinical Study Site | Boston | Massachusetts | 02131 | Recruiting |
| SOAR Clinical Study Site | Las Vegas | Nevada | 89119 | Active, not recruiting |
| SOAR Clinical Study Site | Brooklyn | New York | 11229 | Recruiting |
| SOAR Clinical Study Site | Memphis | Tennessee | 38119 | Recruiting |
| SOAR Clinical Study Site | Austin | Texas | 78737 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07323784, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 8, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07323784 live on ClinicalTrials.gov.